Why JB Chemicals & Pharmaceuticals Share Price is Falling?

As of 30 June 2025, the Indian stock markets opened on a muted note and are trading slightly lower amid mixed sectoral performance and cautious investor sentiment.

At the time of writing, the Nifty 50 index is trading 80 points lower at 25,555 points. The BSE Sensex is down 294 points at 83,764 points.

Auto and financial stocks are weighing on the indices, with major losers including Hero MotoCorp, Dr Reddy's Labs, Tata Consumer, and Kotak Mahindra Bank.

A stock that fell sharply today is JB Chemicals & Pharmaceuticals (JB Chemicals).

Here is a reason for a sharp fall in the stock.

Torrent Pharmaceuticals to Acquire Company

JB Chemicals & Pharmaceuticals announced that Torrent Pharmaceuticals will acquire a 46.39% stake in the company from KKR for Rs 119.17 bn at Rs 1,600 per share.

Torrent Pharmaceuticals may also acquire up to 2.8% equity from certain employees and will make an open offer to public shareholders for an additional 26% stake at Rs 1,639.18 per share.

Subsequently, Torrent Pharmaceuticals and JB Chemicals & Pharmaceuticals will merge, with JB Chemicals & Pharmaceuticals shareholders receiving 51 shares of Torrent Pharmaceuticals for every 100 shares held.

This deal values JB Chemicals & Pharmaceuticals at Rs 256.89 bn on a fully diluted basis and is expected to create a larger diversified pharmaceutical entity.

The share price of JB Chemicals & Pharmaceuticals dropped to align with the price of Torrent Pharmaceuticals, based on the number of shares being received in Torrent Pharmaceuticals.

What Next?

Let's assume you buy 100 shares of JB Chemicals at the current market price of Rs 1,687. You would spend an amount of Rs 168,700.

After the merger you would receive 51 shares of Torrent Pharma. The current share price of Torrent Pharmaceuticals is Rs 3,339, taking the value to Rs 170,289 (51 shares x 3,339). So, the value of your investment will not change much.

After the merger with Torrent Pharmaceuticals, JB Chemicals & Pharmaceuticals will cease to exist. This means the prospects of the merged entity needs to be considered since shareholders will receive Torrent Pharmaceuticals shares.

So, let's take a look at the prospects of the merged entity. The merger will elevate Torrent Pharmaceuticals to the fifth largest pharmaceutical company in India by market share, surpassing some competitors. This scale boost enhances Torrent Pharmaceuticals competitive positioning in the US$ 26 bn Indian pharma market.

Torrent Pharmaceuticals gains JB Chemicals' domestic portfolio. The company has very extensive marketing reach with a strong network of medical representatives. JB Chemicals also has export presence including countries like US, Canada, and South Africa.

JB Chemicals' CDMO (contract development and manufacturing organisation) business is growing. The CDMO market is projected to reach US$ 160 bn by 2028, making this a strategically valuable segment. This should help the merged entity.

The merger is expected to unlock operational synergies, including combining JB Chemicals' CDMO capabilities with Torrent Pharmaceuticals' manufacturing scale, potentially reducing costs. This synergy can enhance profitability and revenue growth.

How Shares of JB Chemicals & Pharmaceuticals have Performed Recently

Over the last one month, the share price of JB Chemicals & Pharmaceuticals has been flat moving marginally higher to the current levels of Rs 1,687 from Rs 1,686.25. The shares of the company have lost 5% in the last one year.

The stock hit a 52-week high of Rs 2,029 on 16 August 2024. The stock hit a 52-week low of Rs 1,303 on 7 April 2025.

About JB Chemicals & Pharmaceuticals

JB Chemicals & Pharmaceuticals is a offers a diverse product portfolio spanning multiple therapeutic categories including gastroenterology, hypertension, dermatology, nephrology, respiratory, virology, diabetes, and nicotine replacement therapy, among others.

The company has a significant CDMO business, which is expanding steadily and is a key growth driver.

It's currently undergoing acquisition by Torrent Pharmaceuticals in a deal valued at approximately Rs 256.89 bn, which includes a planned merger to create a larger, more diversified pharmaceutical entity.

To know more, you can check out JB Chemicals & Pharmaceuticals fact sheet latest quarterly results. You can also compare JB Chemicals & Pharmaceuticals with its peers on our website.

JB Chemicals & Pharmaceuticals vs Caplin Point

JB Chemicals & Pharmaceuticals vs Gland Pharma

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

Investors should evaluate the company's fundamentals, corporate governance, and valuations of the stock as key factors when conducting due diligence before making investment decisions.

Disclaimer: This article is for educational purposes only. It is not a recommendation and should not be treated as such. Learn more about our recommendation services here...